Area of research
Cancer Research · Genetics
Research interest
Research interests include Cancer Genomics and Diagnostics, Chronic Lymphocytic Leukemia Research, Hematopoietic Stem Cell Transplantation, and CAR-T cell therapy research.
Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia
Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations
Author Correction: Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma
cyCombine allows for robust integration of single-cell cytometry datasets within and across technologies
The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia
Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC
Natural Barcodes for Longitudinal Single Cell Tracking of Leukemic and Immune Cell Dynamics
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma
Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy
Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatment
Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History
Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors
Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling
Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy
Author Correction: A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors